Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences ; volume:45 ; number:3 ; day:28 ; month:3 ; year:2023 ; pages:681-688 ; date:6.2023
International journal of clinical pharmacy ; 45, Heft 3 (28.3.2023), 681-688, 6.2023
- Urheber
-
Al Rowily, Abdulrhman
Aloudah, Nouf
Jalal, Zahraa
Abutaleb, Mohammed
Baraka, Mohamed
Paudyal, Vibhu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11096-023-01555-3
- URN
-
urn:nbn:de:101:1-2023091615393432467213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al Rowily, Abdulrhman
- Aloudah, Nouf
- Jalal, Zahraa
- Abutaleb, Mohammed
- Baraka, Mohamed
- Paudyal, Vibhu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases